Pathologic complete response in rectal cancer: advocating for local excision. [PDF]
Gonzalez-Nunez D +3 more
europepmc +1 more source
ABSTRACT Background The optimal therapeutic strategy for patients with T2‐3N0‐3 M0 or T1N1‐3 M0 hypopharyngeal squamous cell carcinoma (HPSCC) and the use of postoperative radiotherapy with or without systemic therapy for patients with T1‐2N1M0 HPSCC remain controversial.
Zhangwei Hu +8 more
wiley +1 more source
Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital. [PDF]
Bauer L +11 more
europepmc +1 more source
Our study identified glioma phenotypic subtypes based on T1CE and T2FLAIR radiomic features, along with associated pathway activities, providing real‐time insights into tumor dynamics to guide preoperative clinical decision‐making and improve patient management.
Junyu Yan +9 more
wiley +1 more source
Total Neoadjuvant Therapy Versus Conventional Chemoradiotherapy in Rectal Cancer: Impact on Tumor Regression Grade and the Predictive Value of CEA. [PDF]
Sarafi A +5 more
europepmc +1 more source
Carcinosarcoma of the Parotid With Osteosarcoma Component: A Case Report
ABSTRACT Carcinosarcomas of the salivary gland with osteosarcoma component are very rare, with only 17 cases reported. Despite multiple poor prognostic factors, our patient's outcome was favorable, highlighting the importance of early diagnosis and aggressive treatment in improving prognosis for this aggressive tumor variant.
Shubham Dokania +8 more
wiley +1 more source
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial. [PDF]
Zheng X +15 more
europepmc +1 more source
231P: Prognostic factors for survival in unresectable stage III non-small cell lung cancer (NSCLC) receiving chemoradiotherapy (CRT) [PDF]
Jie Zhou +6 more
openalex +1 more source

